|Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma …|
PG Morris, DD Correa, J Yahalom, JJ Raizer, D Schiff, B Grant, S Grimm, ...
Journal of Clinical Oncology 31 (31), 3971, 2013
|Background parenchymal enhancement at breast MR imaging and breast cancer risk|
V King, JD Brooks, JL Bernstein, AS Reiner, MC Pike, EA Morris
Radiology 260 (1), 50-60, 2011
|Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study|
M Stovall, SA Smith, BM Langholz, JD Boice Jr, RE Shore, M Andersson, ...
International Journal of Radiation Oncology* Biology* Physics 72 (4), 1021-1030, 2008
|Risk of arterial thromboembolism in patients with cancer|
BB Navi, AS Reiner, H Kamel, C Iadecola, PM Okin, MSV Elkind, ...
Journal of the American College of Cardiology 70 (8), 926-938, 2017
|Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy|
PG Morris, AS Reiner, OR Szenberg, JL Clarke, KS Panageas, HR Perez, ...
Journal of Thoracic Oncology 7 (2), 382-385, 2012
|Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study|
NE Thomas, KJ Busam, L From, A Kricker, BK Armstrong, H Anton-Culver, ...
Journal of Clinical Oncology 31 (33), 4252, 2013
|Patterns of care in elderly glioblastoma patients|
FM Iwamoto, AS Reiner, KS Panageas, EB Elkin, LE Abrey
Annals of Neurology: Official Journal of the American Neurological …, 2008
|Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2|
KE Malone, CB Begg, RW Haile, A Borg, P Concannon, L Tellhed, S Xue, ...
Journal of clinical oncology 28 (14), 2404, 2010
|Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid|
AM Miller, RH Shah, EI Pentsova, M Pourmaleki, S Briggs, N Distefano, ...
Nature 565 (7741), 654-658, 2019
|Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma|
C Grommes, A Pastore, N Palaskas, SS Tang, C Campos, D Schartz, ...
Cancer discovery 7 (9), 1018-1029, 2017
|Association between incident cancer and subsequent stroke|
BB Navi, AS Reiner, H Kamel, C Iadecola, MSV Elkind, KS Panageas, ...
Annals of neurology 77 (2), 291-300, 2015
|Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma|
NE Thomas, SN Edmiston, A Alexander, PA Groben, E Parrish, A Kricker, ...
JAMA oncology 1 (3), 359-368, 2015
|Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study|
JL Bernstein, RW Haile, M Stovall, JD Boice Jr, RE Shore, B Langholz, ...
Journal of the National Cancer Institute 102 (7), 475-483, 2010
|Glioblastoma in the elderly: the Memorial Sloan‐Kettering Cancer Center Experience (1997‐2007)|
FM Iwamoto, AR Cooper, AS Reiner, L Nayak, LE Abrey
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
|Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental …|
AS Reiner, EM John, JD Brooks, CF Lynch, L Bernstein, L Mellemkjær, ...
J Clin Oncol 31 (4), 433-439, 2013
|Intracerebral and subarachnoid hemorrhage in patients with cancer|
BB Navi, JS Reichman, D Berlin, AS Reiner, KS Panageas, AZ Segal, ...
Neurology 74 (6), 494-501, 2010
|Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma|
A Omuro, TA Chan, LE Abrey, M Khasraw, AS Reiner, TJ Kaley, ...
Neuro-oncology 15 (2), 242-250, 2013
|Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study|
NE Thomas, A Kricker, WT Waxweiler, PM Dillon, KJ Busam, L From, ...
JAMA dermatology 150 (12), 1306-1314, 2014
|Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma|
A Omuro, K Beal, P Gutin, S Karimi, DD Correa, TJ Kaley, LM DeAngelis, ...
Clinical Cancer Research 20 (19), 5023-5031, 2014
|Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma|
C Grommes, SS Tang, J Wolfe, TJ Kaley, M Daras, EI Pentsova, ...
Blood 133 (5), 436-445, 2019